Loading
NASDAQHealthcareMedical - Devices
Latest quote
$3.68
+$0.26 · +7.60%
Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.
Previous close
$3.68
+$0.26 · +7.60%
Regular session · ET · Market data may be delayed.
Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.
Day range
Current $3.68
52-week range
Current $3.68
Regular session · ET · Market data may be delayed.
AI-powered factor overview
GoAI Score
Sell
Trim exposure — unfavorable risk-reward
Valuation
23
Expensive
Sentiment
68
Bullish
Risk
66
High Risk
Momentum
21
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.
Day range
Current $3.68
52-week range
Current $3.68
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Cost of goods sold | 1.67M USD | — | — | — | — |
| Gross profit | −1.67M USD | — | — | — | — |
| Research and development | 19.97M USD | 14.7M USD | 12.88M USD | 9.06M USD | 7.73M USD |
| Selling, general, and administrative | 7.59M USD | 4.35M USD | 4.65M USD | 4.82M USD | 7.2M USD |
| Operating expenses | 25.89M USD | 19.05M USD | 17.53M USD | 13.88M USD | 14.93M USD |
| Interest expense | — | — | — | — | 2.75M USD |
| Depreciation and amortization | 1.67M USD | 1.06M USD | 426K USD | 152K USD | 117.49K USD |
| Operating income | −27.56M USD | −19.05M USD | −17.53M USD | −13.88M USD | −14.93M USD |
| Net income | −28.24M USD | −18.82M USD | −17.47M USD | −13.88M USD | −18.63M USD |
Company facts updated Sep 5, 2026.
Third-party consensus; not a GoAI recommendation.
Limited analyst sample: 3 ratings. Interpret the distribution with caution.
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
